A Clinical Study to Evaluate the Safety and Therapeutic Efficacy of Safuf-e-Chobchini in the Management of Waja-al-Mafasil (Rheumatoid Arthritis); A Block Randomised,Open label,Standard Control Study. - Nil

Central Council for Research in Unani Medicine , New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•1.Patients in the age group of 18 to 65 years.
•2.Patients irrespective of gender.
•3.Patients who fulfill the criteria of the New American College of Rheumatology European League Against Rheumatism 2010 for the diagnosis of rheumatoid arthritis.
•4. Patients, who are ready to sign the informed consent, follow the protocol and willing to participate in the clinical study voluntarily.

•1.Women who are pregnant, planning pregnancy, or breast feeding.
•2.Patients with systemic,extra-articular manifestations of rheumatoid arthritis.
•3.Patients having gouty arthritis and psoriatic arthritis.
•4.Patients with history of systemic disease like uncontrolled diabetes mellitus and hypertension,hepatic dysfunction and impaired renal function.
•5.Patients currently receiving or have received intra-articular treatment, oral or parenteral corticosteroids, or NSAIDs within 2 weeks, DMARDs or anticipated IFN therapy within 4 weeks prior to study entry.
•6.Obese subjects with BMI =35

发起方

Central Council for Research in Unani Medicine , New Delhi